6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Activation of the receptor for advanced glycation end products and consequences on health.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Advanced glycation end products (AGE) resulted from a reaction between free amino group of proteins and carbohydrates. This reaction is followed by oxidation and molecular rearrangement. Alternatively AGEs can be produced by glycolysis and oxidation. AGEs bind to a cellular receptor RAGE. RAGE engagement by ligands AGE, β-amyloid peptide, and S100 calgranulin induces a stimulation of NADPH oxidase, reactive oxygen intermediate formation, NFκB activation and gene transcription. This cascade of reaction leads to an inflammatory reaction responsible for alteration of microvessels in the retina and the kidney. Blockade of RAGE by antibodies anti-RAGE, TTP488 (azeliragon), or rRAGE prevents or limits the deleterious effect of AGEs.

          Related collections

          Author and article information

          Journal
          Diabetes Metab Syndr
          Diabetes & metabolic syndrome
          Elsevier BV
          1878-0334
          1871-4021
          September 11 2016
          : 11
          : 4
          Affiliations
          [1 ] Laboratoire de Biologie Vasculaire et Cellulaire, 6 rue Alexandre Cabanel, 75015 Paris, France.
          [2 ] Université Denis Diderot Paris 7, 10 avenue de Verdun, 75010 Paris, France; APHP, Département de Médecine Interne, Hôpital Lariboisière 2 rue Ambroise Paré, 75010 Paris, France.
          [3 ] Université Denis Diderot Paris 7, 10 avenue de Verdun, 75010 Paris, France; Laboratoire de Biologie Vasculaire et Cellulaire, 6 rue Alexandre Cabanel, 75015 Paris, France. Electronic address: jltwautier@gmail.com.
          Article
          S1871-4021(16)30208-9
          10.1016/j.dsx.2016.09.009
          27612394
          25c91660-9c81-4938-af89-0906c2f9a89d
          History

          Receptor for advanced glycation end products,Cell activation,Diabetes mellitus,Glycation,RAGE blockers

          Comments

          Comment on this article